According to Poseida Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.24. In 2022 the company made an earnings per share (EPS) of -$1.09 an increase over its 2021 EPS that were of -$2.02.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$0.24 | -77.98% |
2022 | -$1.09 | -46.04% |
2021 | -$2.02 | -9.59% |
2020 | -$2.23 | 2.59% |
2019 | -$2.18 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$2.18 | 808.33% | ๐บ๐ธ USA |